InterVest stake in Bio Protech falls to 3.84% from 11.37% after conversion adjustment

• InterVest disclosed a change in its stake in Bio Protech, citing common-share conversion triggered by a refixing adjustment.
• Holdings rose to 867,935 shares from 626,666 shares as of Oct. 2, 2026.
• Voting rights fell to 3.84% from 11.37%, reflecting a sharp increase in total voting shares outstanding.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Protech Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002000667), on October 02, 2026, and is solely responsible for the information contained therein.